Evusheld

(asked on 15th May 2023) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department has taken recent steps to fast-track the approval of the Evusheld vaccine.


Answered by
Will Quince Portrait
Will Quince
This question was answered on 22nd May 2023

The National Institute for Health and Care Excellence (NICE) is the independent, expert body responsible for developing authoritative, evidence-based recommendations for the National Health Service on whether new medicines represent a clinically and cost-effective use of resources. The Government asked NICE to evaluate Evusheld for the prevention of COVID-19 through its technology appraisal programme in August 2022. NICE has been able to expedite the evaluation of Evusheld and released its final draft guidance on 5 May following a consultation on its draft recommendations earlier this year. NICE has unfortunately been unable to recommend Evusheld as a clinically and cost effective use of NHS resources, citing a lack of clinical evidence of its effectiveness against currently circulating variants. NICE has not yet published its final guidance.

Reticulating Splines